Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The US Food and Drug Administration (FDA) has taken action to support recovery from Hurricane Florence, particularly to prevent drug shortages from pharmaceutical companies manufacturing important drugs. The hurricane struck North Carolina, South...

Allergan has agreed to acquire Bonti, a Newport Beach, California-based clinical-stage biopharmaceutical company focused on developing and commercializing fast-acting neurotoxin programs for aesthetic and therapeutic applications. Following...

The US Senate has passed The Opioid Crisis Response Act of 2018, bipartisan legislation that included over 70 proposals from five Senate committees to address the challenge of opioid misuse in the US. The bill, passed in a vote of 99-1, will now...

GlaxoSmithKline (GSK) has invested $36 million to modernize its site in Mississauga, Ontario, Canada into a consumer healthcare and prescription supply site. The investment enabled facility modifications, new equipment purchases, and enhanced...

Sanofi has announced plans to change the organizational structure of two of its global business units (GBUs) to provide greater focus on its operations in mature markets and emerging markets. The company says it will create a new Primary Care GBU...

Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, plans to invest approximately $800 million over seven years to expand its laboratory space, manufacturing capacity, and warehouse facilities at the company's campus...

Following a business review, GlaxoSmithKline (GSK) has announced staff reductions of up to 650 employees across its US business, primarily in sales and back-office operations. These changes are part of global restructuring program, announced by...